Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferran Prados

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Annals of Clinical and Translational Neurology|September 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexaroteneJ William L Brown, Ferran Prados, Daniel R Altmann, et al.
JAMA Neurology|August 11, 2025
Slowly Expanding Lesions in Pediatric-Onset Multiple SclerosisValeria Pozzilli, Ferran Prados Carrasco, Neena Kim, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
European Journal of Neurology|June 15, 2023
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension studyHans-Peter Hartung, Tobias Derfuss, Bruce Ac Cree, et al.
European Radiology|April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosisDavid R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2022
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel BiomarkersGilbert Thomas-Black, Daniel R Altmann, Harry Crook, et al.
Neuroimage. Reports|September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
European Radiology|August 5, 2020
Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosisOlivia Goodkin, Hugh G Pemberton, Sjoerd B Vos, et al.
BMJ Open|September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosisPeter Connick, Floriana De Angelis, Richard A Parker, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Annals of Clinical and Translational Neurology|September 18, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexaroteneJ William L Brown, Ferran Prados, Daniel R Altmann, et al.
JAMA Neurology|August 11, 2025
Slowly Expanding Lesions in Pediatric-Onset Multiple SclerosisValeria Pozzilli, Ferran Prados Carrasco, Neena Kim, et al.
Journal of Magnetic Resonance Imaging : JMRI|October 3, 2023
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsNevin A John, Bhavana S Solanky, Floriana De Angelis, et al.
European Journal of Neurology|June 15, 2023
Cardiovascular risk factors in secondary progressive multiple sclerosis: A cross-sectional analysis from the MS-STAT2 randomized controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 9, 2021
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension studyHans-Peter Hartung, Tobias Derfuss, Bruce Ac Cree, et al.
European Radiology|April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosisDavid R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 26, 2022
Multimodal Analysis of the Visual Pathways in Friedreich's Ataxia Reveals Novel BiomarkersGilbert Thomas-Black, Daniel R Altmann, Harry Crook, et al.
Neuroimage. Reports|September 27, 2024
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trialThomas Williams, Nevin John, Alberto Calvi, et al.
European Radiology|August 5, 2020
Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosisOlivia Goodkin, Hugh G Pemberton, Sjoerd B Vos, et al.
BMJ Open|September 1, 2018
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosisPeter Connick, Floriana De Angelis, Richard A Parker, et al.
Pageof 17